{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:37:15Z","timestamp":1761061035398,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12350-020-02124-1","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T15:02:35Z","timestamp":1588777355000},"page":"1439-1445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology?"],"prefix":"10.1016","volume":"29","author":[{"given":"Wanda","family":"Acampa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"D\u2019Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Imbriaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cuocolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02124-1_bib1","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1007\/s12350-020-02124-1_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1007\/s12350-020-02124-1_bib3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","article-title":"Proposed stages of myocardial phenotype development in Fabry disease","volume":"12","author":"Nordin","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cge.12386","article-title":"The kidney in Fabry\u2019s disease","volume":"86","author":"Pisani","year":"2014","journal-title":"Clin Genet"},{"key":"10.1007\/s12350-020-02124-1_bib5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","article-title":"The role of cardiac imaging in the diagnosis and management of Anderson\u2013Fabry disease","volume":"12","author":"Perry","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: A key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1007\/s12350-020-02124-1_bib7","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson\u2013Fabry disease: Results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-020-02124-1_bib8","article-title":"New insights for early assessment of cardiac involvement in Anderson\u2013Fabry disease","author":"Cuocolo","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02124-1_bib9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2214\/AJR.05.0442","article-title":"MRI characterization of myocardial tissue in patients with Fabry\u2019s disease","volume":"188","author":"Imbriaco","year":"2007","journal-title":"Am J Roentgenol"},{"key":"10.1007\/s12350-020-02124-1_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/hrt.2008.162800","article-title":"Effects of enzyme replacement therapy in patients with Anderson\u2013Fabry disease: A prospective long-term cardiac magnetic resonance imaging study","volume":"95","author":"Imbriaco","year":"2009","journal-title":"Heart"},{"key":"10.1007\/s12350-020-02124-1_bib11","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1259\/bjr\/52065763","article-title":"Cardiac magnetic resonance imaging illustrating Anderson\u2013Fabry disease progression","volume":"83","author":"Imbriaco","year":"2010","journal-title":"Br J Radiol"},{"key":"10.1007\/s12350-020-02124-1_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson\u2013Fabry disease by cardiovascular magnetic resonance non contrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1148\/radiol.2019191385","article-title":"Left ventricular hypertrophy and late gadolinium enhancement at cardiac MRI are associated with adverse cardiac events in Fabry disease","volume":"294","author":"Hanneman","year":"2020","journal-title":"Radiology"},{"key":"10.1007\/s12350-020-02124-1_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/heartjnl-2018-313699","article-title":"Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease","volume":"105","author":"Vijapurapu","year":"2019","journal-title":"Heart"},{"key":"10.1007\/s12350-020-02124-1_bib16","article-title":"Early cardiac involvement affects left ventricular longitudinal function in females carrying a-galactosidase A mutation: Role of hybrid positron emission tomography and magnetic resonance imaging and speckle-tracking echocardiography","volume":"11","author":"Spinelli","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2967\/jnumed.112.112524","article-title":"EANM\/SNMMI guideline for 18F-FDG use in inflammation and infection","volume":"54","author":"Jamar","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02124-1_bib18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2016.07.741","article-title":"Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy","volume":"68","author":"Nordin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02124-1_bib19","first-page":"14","article-title":"Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment","volume":"28","author":"O h-Ici","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-020-02124-1_bib20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00259-015-3036-3","article-title":"First experience of simultaneous PET\/MRI for the early detection of cardiac involvement in patients with Anderson\u2013Fabry disease","volume":"42","author":"Nappi","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib21","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/ehjci\/jez039","article-title":"Hybrid positron emission tomography magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson\u2013Fabry disease: AFFINITY study group","volume":"20","author":"Imbriaco","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib22","first-page":"1862","article-title":"Sympathetic reinnervation demonstrated on serial iodine-123-metaiodobenzylguanidine SPECT images after cardiac transplantation","volume":"39","author":"Toba","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02124-1_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12350-016-0697-7","article-title":"Myocardial 123I-MIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure","volume":"25","author":"Verschure","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02124-1_bib24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00415-012-6800-3","article-title":"Small fibre neuropathy in Fabry disease","volume":"260","author":"Bertelsen","year":"2013","journal-title":"J Neurol"},{"key":"10.1007\/s12350-020-02124-1_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4236\/ojim.2012.22021","article-title":"Autonomic nervous system activity in patients with Fabry disease","volume":"2","author":"Alamartine","year":"2012","journal-title":"Open J Intern Med"},{"key":"10.1007\/s12350-020-02124-1_bib26","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00259-017-3778-1","article-title":"Cuocolo, Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson\u2013Fabry disease","volume":"44","author":"Imbriaco","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib27","article-title":"Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson\u2013Fabry disease","author":"Spinelli","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02124-1_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/ATVBAHA.113.302744","article-title":"Globotriaosylceramide induces endothelial dysfunction in Fabry disease","volume":"34","author":"Satoh","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1007\/s12350-020-02124-1_bib29","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.114.012178","article-title":"Microvascular angina as prehypertrophic presentation of Fabry disease cardiomiopathy","volume":"130","author":"Frustaci","year":"2014","journal-title":"Circulation"},{"key":"10.1007\/s12350-020-02124-1_bib30","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2967\/jnumed.108.054478","article-title":"The clinical value of myocardial blood flow measurement","volume":"50","author":"Camici","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02124-1_bib31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00259-017-3671-y","article-title":"Coronary atherosclerotic burden vs. coronary vascular function in diabetic and nondiabetic patients with normal myocardial perfusion: A propensity score analysis","volume":"44","author":"Assante","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-020-02124-1_bib32","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1007\/s00259-017-3800-7","article-title":"Prognostic value of atherosclerotic burden and coronary vascular function in patients with suspected coronary artery disease","volume":"44","author":"Assante","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00259-018-3935-1","article-title":"Combined evaluation of regional coronary artery calcium and myocardial perfusion by (82)Rb PET\/CT in the identification of obstructive coronary artery disease","volume":"45","author":"Zampella","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib34","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2967\/jnumed.111.101840","article-title":"Diagnostic value of 13N-Ammonia myocardial perfusion PET: Added value of myocardial flow reserve","volume":"53","author":"Fiechter","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02124-1_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2967\/jnumed.111.095398","article-title":"Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-Ammonia PET\/CT","volume":"53","author":"Slomka","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02124-1_bib36","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2967\/jnumed.114.145342","article-title":"Comparison and prognostic validation of multiple methods of quantification of myocardial blood flow with 82Rb PET","volume":"55","author":"Murthy","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02124-1_bib37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/ehjci\/jez025","article-title":"Coronary vascular function in patients with resistant hypertension and normal myocardial perfusion: A propensity score analysis","volume":"20","author":"Gaudieri","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02124-1_bib38","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/eurjhf\/hft104","article-title":"Coronary microvascular dysfunction is a nearly feature of cardiac involvement in patients with Anderson\u2013Fabry disease","volume":"15","author":"Tomberli","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1007\/s12350-020-02124-1_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase: A replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1007\/s12350-020-02124-1_bib40","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: A randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1007\/s12350-020-02124-1_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2008.03.003","article-title":"Treatment of Fabry disease with different dosing regimens of agalsidase: Effects on antibody formation and GL-3","volume":"94","author":"Vedder","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1007\/s12350-020-02124-1_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/cge.13546","article-title":"Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients","volume":"96","author":"Germain","year":"2019","journal-title":"Clin Genet"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02124-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02124-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123003318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123003318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02124-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:12:51Z","timestamp":1761027171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123003318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1071358123003318"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02124-1","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology?","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02124-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}